GE HealthCare Technologies Inc. (GEHC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 2B 4B 6B Q1 '22: 4.3B Q2 '22: 4.5B Q3 '22: 4.6B Q4 '22: 4.9B Q1 '23: 4.7B Q2 '23: 4.8B Q3 '23: 4.8B Q4 '23: 5.2B Q1 '24: 4.7B Q2 '24: 4.8B Q3 '24: 4.9B Q4 '24: 5.3B Q1 '25: 4.8B Q2 '25: 5B Q3 '25: 5.1B Q4 '25: 5.7B Q1 '26: 5.1B Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Gross Profit Quarterly

0 800M 1.6B 2.4B Q1 '22: 1.7B Q2 '22: 1.8B Q3 '22: 1.8B Q4 '22: 1.9B Q1 '23: 1.9B Q2 '23: 1.9B Q3 '23: 1.9B Q4 '23: 2.2B Q1 '24: 1.9B Q2 '24: 2B Q3 '24: 2B Q4 '24: 2.3B Q1 '25: 2B Q2 '25: 2B Q3 '25: 2B Q4 '25: 2.3B Q1 '26: 2B Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Operating Income Quarterly

0 300M 600M 900M Q1 '22: 509M Q2 '22: 631M Q3 '22: 605M Q4 '22: 777M Q1 '23: 559M Q2 '23: 570M Q3 '23: 617M Q4 '23: 689M Q1 '24: 540M Q2 '24: 608M Q3 '24: 676M Q4 '24: 801M Q1 '25: 629M Q2 '25: 654M Q3 '25: 653M Q4 '25: 827M Q1 '26: 515M Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Net Income Quarterly

0 250M 500M 750M Q1 '22: 389M Q2 '22: 485M Q3 '22: 487M Q4 '22: 554M Q1 '23: 372M Q2 '23: 418M Q3 '23: 375M Q4 '23: 403M Q1 '24: 374M Q2 '24: 428M Q3 '24: 470M Q4 '24: 721M Q1 '25: 564M Q2 '25: 486M Q3 '25: 446M Q4 '25: 589M Q1 '26: 389M Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-400M 0 400M 800M 1.2B Q1 '22: 468M Q2 '22: -19M Q3 '22: 622M Q4 '22: 1.1B Q1 '23: 468M Q2 '23: -67M Q3 '23: 650M Q4 '23: 1.1B Q1 '24: 419M Q2 '24: -119M Q3 '24: 742M Q4 '24: 913M Q1 '25: 250M Q2 '25: 94M Q3 '25: 593M Q4 '25: 1.1B Q1 '26: 290M Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Free Cash Flow Quarterly

-350M 0 350M 700M 1.1B Q1 '22: 368M Q2 '22: -78M Q3 '22: 548M Q4 '22: 986M Q1 '23: 325M Q2 '23: -137M Q3 '23: 570M Q4 '23: 956M Q1 '24: 274M Q2 '24: -183M Q3 '24: 652M Q4 '24: 811M Q1 '25: 98M Q2 '25: 8M Q3 '25: 483M Q4 '25: 916M Q1 '26: 112M Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 200M 400M 600M Q1 '22: 454M Q2 '22: 454M Q3 '22: 454M Q1 '23: 457M Q2 '23: 458M Q3 '23: 458M Q1 '24: 459M Q2 '24: 459M Q3 '24: 459M Q1 '25: 459M Q2 '25: 458M Q3 '25: 457M Q1 '26: 457M Q1 '22 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 2.00 4.00 6.00 Q4 '22: 4.22 Q1 '23: 3.77 Q2 '23: 3.61 Q3 '23: 3.36 Q4 '23: 3.02 Q1 '24: 3.42 Q2 '24: 3.44 Q3 '24: 3.64 Q4 '24: 4.33 Q1 '25: 4.75 Q2 '25: 4.88 Q3 '25: 4.84 Q4 '25: 4.56 Q1 '26: 4.18 Q1 '23 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.